Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates. 2010

G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia.

This paper reviews previously published data and presents new results to address the hypothesis that fluorinated aminophosphonates (FAPs), (RO)(2)P(O)C(CF(3))(2)NHS(O)(2)C(6)H(5), R=alkyl, inhibit serine esterases by scission of the P-C bond. Kinetics studies demonstrated that FAPs are progressive irreversible inhibitors of acetylcholinesterase (AChE, EC 3.1.1.7.), butyrylcholinesterase (BChE, EC 3.1.1.8.), carboxylesterase (CaE, EC 3.1.1.1.), and neuropathy target esterase (NTE, EC 3.1.1.5.), consistent with P-C bond breakage. Chemical reactivity experiments showed that diMe-FAP and diEt-FAP react with water to yield the corresponding dialkylphosphates and (CF(3))(2)CHNHS(O)(2)C(6)H(5), indicating lability of the P-C bond. X-ray crystallography of diEt-FAP revealed an elongated (and therefore weaker) P-C bond (1.8797 (13)A) compared to P-C bonds in dialkylphosphonates lacking alpha-CF(3) groups (1.805-1.822A). Semi-empirical and non-empirical molecular modeling of diEt-FAP and (EtO)(2)P(O)C(CH(3))(2)NHS(O)(2)C(6)H(5) (diEt-AP), which lacks CF(3) groups, indicated lengthening and destabilization of the P-C bond in diEt-FAP compared to diEt-AP. Active site peptide adducts formed by reacting diEt-FAP with BChE and diBu-FAP with NTE catalytic domain (NEST) were identified using peptide mass mapping with mass spectrometry (MS). Mass shifts (mean+/-SE, average mass) for peaks corresponding to active site peptides with diethylphosphoryl and monoethylphosphoryl adducts on BChE were 136.1+/-0.1 and 108.0+/-0.1Da, respectively. Corresponding mass shifts for dibutylphosphoryl and monobutylphosphoryl adducts on NEST were 191.8+/-0.2 and 135.5+/-0.1Da, respectively. Each of these values was statistically identical to the theoretical mass shift for each dialkylphosphoryl and monoalkylphosphoryl species. The MS results demonstrate that inhibition of BChE and NEST by FAPs yields dialkylphosphoryl and monoalkylphosphoryl adducts, consistent with phosphorylation via P-C bond cleavage and aging by net dealkylation. Taken together, predictions from enzyme kinetics, chemical reactivity, X-ray crystallography, and molecular modeling were confirmed by MS and support the hypothesis that FAPs inhibit serine esterases via scission of the P-C bond.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010449 Peptide Mapping Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases. Fingerprints, Peptide,Peptide Fingerprinting,Protein Fingerprinting,Fingerprints, Protein,Fingerprint, Peptide,Fingerprint, Protein,Fingerprinting, Peptide,Fingerprinting, Protein,Mapping, Peptide,Peptide Fingerprint,Peptide Fingerprints,Protein Fingerprint,Protein Fingerprints
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004950 Esterases Any member of the class of enzymes that catalyze the cleavage of an ester bond and result in the addition of water to the resulting molecules. Esterase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D054879 Halogenation Covalent attachment of HALOGENS to other compounds. Bromination,Chlorination,Fluorination,Iodination,Iodation

Related Publications

G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
April 1989, Biochemistry,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
November 2008, Biochemistry,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
July 1968, The Journal of biological chemistry,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
March 1993, Xenobiotica; the fate of foreign compounds in biological systems,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
April 2013, The Journal of organic chemistry,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
January 1981, Ukrainskii biokhimicheskii zhurnal (1978),
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
July 1965, Molecular pharmacology,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
January 2020, Beilstein journal of organic chemistry,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
October 2004, Toxicology and applied pharmacology,
G F Makhaeva, and A Y Aksinenko, and V B Sokolov, and I I Baskin, and V A Palyulin, and N S Zefirov, and N D Hein, and J W Kampf, and S J Wijeyesakere, and R J Richardson
January 1991, Biochemical pharmacology,
Copied contents to your clipboard!